Search bioRxivSearch

bioRxiv · 10.1101/459503

A comparison of bivariate frequency domain measures of electrophysiological connectivity

Abstract

1The problem of interest here concerns electrophysiological signals from two cortical sites, acquired as invasive intracranial recordings, or from non-invasive estimates of cortical electric neuronal activity computed from EEG or MEG recordings (see e.g. https://doi.org/10.1101/269753). In the absence of other sources, these measured signals consist of an instantaneous linear mixture of the true, actual, unobserved local signals, due to low spatial resolution and volume conduction. A connectivity measure is unreliable as a true indicator of electrophysiological connectivity if it is not invariant to mixing, or if it reports a significant connection for a mixture of independent signals. In (Vinck et al 2011 Neuroimage 55:1548) it was shown that coherence, imaginary coherence, and phase locking value are not invariant to mixing, while the phase lag index (PLI) and the weighted version (wPLI) are invariant to mixing. Here we show that the lagged coherence (LagCoh) measure (2007, https://arxiv.org/abs/0711.1455), not studied in Vinck et al, is invariant to mixing. Additionally, we present here a new mixture-invariant connectivity statistic: the \"standardized imaginary covariance\" (sImCov). We also include in the comparisons the directed PLI (dPLI) by Stam et al (2012 Neuroimage 62:1415). Fourier coefficients for \"N\" trials are generated from a linear unidirectional causal time domain model with electrophysiological delay \"k\" and regression coefficient \"b\". 1000 random data sets of \"N\" trials are simulated, and for each one, and for each connectivity measure, non-parametric randomization tests are performed. The \"true positive detection rate\" is calculated as the fraction of 1000 cases that have significant connectivity at p<0.05, 0.1, and 0.2. The connectivity methods were compared in terms of detection rates, under non-mixed and mixed conditions, for small and large sample sizes \"N\", with and without jitter for \"k\", and for different values of signal to noise. Under mixing, the results show that LagCoh outperforms wPLI, PLI, dPLI, and sImCov. Without mixing, LagCoh and sImCov outperform wPLI, PLI, and dPLI. Finally, it is shown that dPLI is an invalid estimator of flow direction, i.e. it reverses and \"goes against the flow\" by merely changing the sign of one of the time series, a fact that violates the basic definition of Granger causality. For the sake of reproducible research, the supplementary material includes Delphi Pascal source code and all detailed result files in human readable format.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Pascual-Marqui, R. D., Faber, P., Kinoshita, T., Kochi, K., Milz, P., Nishida, K., Yoshimura, M.. 2018-11-01. A comparison of bivariate frequency domain measures of electrophysiological connectivity. https://doi.org/10.1101/459503

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience